Abstract CN07-03: Recombinant immunotoxins for hematologic malignancies
Robert J. Kreitman(National Cancer Institute), Ira Pastan(National Institutes of Health), Katherine Potocka(National Institutes of Health), Daniel Gorelik(National Institutes of Health), Hong Zhou(National Cancer Institute), Maryalice Stetler‐Stevenson(National Cancer Institute), Evgeny Arons(National Institutes of Health), Erin Fykes(National Institutes of Health), Hao‐Wei Wang(Fu Jen Catholic University), Constance M. Yuan(National Cancer Institute)
Cited by 0
Related Papers
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
α-Galactosidase A deficient mice: A model of Fabry disease
|Proceedings of the National Academy of Sciences|1997|370